NRx Pharmaceuticals, Inc. (NRXP) Ownership
NRXP ownership summary
as of October 18, 2026- Institutions
- 27.1% of shares outstanding
- Insiders
- 4.12% of shares outstanding
- Shares outstanding
- 43.3M
- Float
- 37.4M shares available to trade
- Short interest
- 23.59% 9.8M shares short
- Days to cover
- 15.10 short interest up 0.2% vs prior month
- Institutions 27.13%
- Insiders 4.12%
- Other investors 68.76%
NRXP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | B Group, Inc | 9.45% | 4.1M | $10.6M | +1.1M (+36.4%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 3.74% | 1.6M | $4.2M | +457,975 (+39.5%) | June 30, 2026 |
| 3 | Ameriprise Financial Inc | 2.15% | 929K | $2.4M | +928,728 (0.0%) | June 30, 2026 |
| 4 | Balyasny Asset Management LLC | 2.06% | 894K | $2.3M | +893,864 (0.0%) | June 30, 2026 |
| 5 | Citadel Advisors Llc | 1.57% | 680K | $1.8M | +680,043 (0.0%) | June 30, 2026 |
| 6 | AdvisorShares Investments, LLC | 1.52% | 659K | $1.7M | +238,551 (+56.7%) | June 30, 2026 |
| 7 | Commonwealth Equity Services, LLC | 1.05% | 454K | $1.2M | +56,987 (+14.3%) | June 30, 2026 |
| 8 | UBS Group AG | 0.98% | 423K | $1.1M | +397,888 (+1,577.2%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 0.73% | 315K | $818,113 | +4,547 (+1.5%) | June 30, 2026 |
| 10 | BlackRock Inc | 0.51% | 220K | $573,196 | +121,465 (+122.7%) | June 30, 2026 |
| 11 | Marshall Wace Asset Management Ltd | 0.45% | 195K | $505,908 | +194,580 (0.0%) | June 30, 2026 |
| 12 | Vanguard Fiduciary Trust Co | 0.42% | 183K | $475,067 | +13,138 (+7.7%) | June 30, 2026 |
| 13 | Jane Street Group LLC | 0.27% | 119K | $309,447 | +74,866 (+169.6%) | June 30, 2026 |
| 14 | Bleakley Financial Group LLC | 0.27% | 117K | $304,762 | +12 (+0.0%) | June 30, 2026 |
| 15 | State Street Corp | 0.27% | 116K | $301,818 | +29,100 (+33.5%) | June 30, 2026 |
| 16 | HRT FINANCIAL LLC | 0.23% | 101K | $261,882 | +100,724 (0.0%) | June 30, 2026 |
| 17 | Northern Trust Corp | 0.15% | 63K | $163,673 | +19,482 (+44.8%) | June 30, 2026 |
| 18 | Chicago Partners Investment Group LLC | 0.11% | 46K | $120,609 | +11,909 (+34.5%) | June 30, 2026 |
| 19 | Quadrature Capital Limited | 0.10% | 44K | $113,373 | +43,605 (0.0%) | June 30, 2026 |
| 20 | One Wealth Management Investment & Advisory Services LLC | 0.10% | 43K | $112,603 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 19 holders added 5.4M shares and 0 cut 0.
NRXP top mutual fund and ETF holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.93% | 1.3M | $3.3M | — | August 31, 2026 |
| 2 | AdvisorShares Psychedelics ETF | 1.86% | 805K | $2.1M | — | September 30, 2026 |
| 3 | Fidelity Extended Market Index | 0.33% | 144K | $374,096 | −773 (−0.5%) | August 31, 2026 |
| 4 | iShares Micro-Cap ETF | 0.25% | 108K | $279,599 | −742 (−0.7%) | September 30, 2026 |
| 5 | Abante Quant Value FI | 0.23% | 101K | $263,817 | — | August 31, 2026 |
| 6 | Fidelity Total Market Index | 0.12% | 50K | $131,167 | — | August 31, 2026 |
| 7 | Mandarine Global Microcap G EUR | 0.12% | 50K | $130,000 | — | June 30, 2026 |
| 8 | Fidelity Series Total Market Index | 0.10% | 45K | $116,542 | +6,413 (+16.7%) | August 31, 2026 |
| 9 | Fidelity Nasdaq Composite Index | 0.05% | 22K | $57,138 | — | August 31, 2026 |
| 10 | Vanguard Balanced Index Inv | 0.05% | 22K | $56,464 | — | August 31, 2026 |
| 11 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.04% | 15K | $40,193 | — | August 31, 2026 |
| 12 | 1290 VT Micro Cap K | 0.01% | 6,244 | $16,234 | −869 (−12.2%) | August 31, 2026 |
| 13 | Vanguard U.S. Eq Idx £ Acc | 0.01% | 5,773 | $15,010 | — | August 31, 2026 |
| 14 | Victory Extended Market Index | 0.01% | 4,275 | $11,115 | +4,275 (0.0%) | June 30, 2026 |
| 15 | JHVIT Total Stock Market Index I | <0.01% | 747 | $1,942 | +113 (+17.8%) | August 31, 2026 |
| 16 | Avantis America Equity ETF USD Acc | <0.01% | 23 | $60 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NRXP insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-17 | Jonathan C Javitt | Buy | $1.17 | 40,000 | $46,800 |
| 2023-08-30 | Aaron Gorovitz | Buy | $3.20 | 3,500 | $11,200 |
| 2023-08-22 | Jonathan C Javitt | Buy | $3.20 | 20,000 | $64,000 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NRXP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NRXP
Institutional investors own 27.1% of NRx Pharmaceuticals's shares and insiders 4.12%. The largest holder is B Group, Inc with 9.45% of the shares (4.1M), as of June 30, 2026. Among the top 20 institutions, 19 added shares and 0 reduced their stake in the latest filings. Short interest is 23.59% of the float, or 15.10 days of average trading volume. The share count rose 1,580.0% since 2017.
Related: NRXP analyst forecast, NRXP key metrics. See the NRXP stock overview for the latest quote and news.
NRXP ownership FAQ
Who owns the most NRx Pharmaceuticals stock?
The largest shareholders of NRx Pharmaceuticals are B Group, Inc (9.45%), Vanguard Capital Management, LLC (3.74%), Ameriprise Financial Inc (2.15%), Balyasny Asset Management LLC (2.06%), Citadel Advisors Llc (1.57%).
What percentage of NRx Pharmaceuticals is owned by institutions?
Institutions hold 27.1% of NRx Pharmaceuticals's shares outstanding; insiders hold 4.12%.
Which funds own NRx Pharmaceuticals?
The largest fund holders of NRx Pharmaceuticals are Vanguard MStar Total Stk Mkt Idx Invest (2.93%), AdvisorShares Psychedelics ETF (1.86%), Fidelity Extended Market Index (0.33%), iShares Micro-Cap ETF (0.25%), Abante Quant Value FI (0.23%).
What is NRx Pharmaceuticals's short interest?
9.8M shares of NRx Pharmaceuticals were sold short, 23.59% of the float; at the average daily volume it would take 15.10 days to cover.
Are insiders buying or selling NRx Pharmaceuticals?
Of the latest 3 reported insider transactions in NRx Pharmaceuticals (since August 22, 2023), 3 were purchases and 0 were sales.
How many shares of NRx Pharmaceuticals are outstanding?
NRx Pharmaceuticals has 43.3M shares outstanding, of which 37.4M are in the public float.